Taking the readiness argument seriously and following it forward, a man on testosterone replacement depends on a delivery schedule rather than his own factory. The episode reasons from pharmacology about axis suppression, missed doses, fertility and the veterans' tail, and notes the department's own argument about pharmaceutical dependence. None of it has happened; it is what the pharmacology implies.
The magnitude and timing of decline after a missed dose in young, previously healthy men have not been studied, and no prevalence data or cost estimate for the program is public. Whether the transgender exclusion rested solely on hormone-therapy grounds is also not established.



